_id

69109507ccc777a4e85d5ace

Ticker

EGRX

Name

Eagle Pharmaceuticals Inc

Exchange

NASDAQ

Address

50 Tice Boulevard, Woodcliff Lake, NJ, United States, 07677

Country

USA

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

Currency

USD

Website

https://www.eagleus.com

Description

Eagle Pharmaceuticals, Inc., a pharmaceutical company, focuses on developing and commercializing product candidates to treat diseases of the central nervous system or metabolic critical care, and oncology in the United States. The company offers Ryanodex for malignant hyperthermia; and Belrapzo and Bendeka for chronic lymphocytic leukemia and indolent B-cell non-Hodgkin's lymphoma. Its product candidates also include EP-4104, a dantrolene sodium to treat organophosphate exposure; PEMFEXY, a ready-to-use/dilute liquid form of pemetrexed for non-small cell lung cancer and mesothelioma; EA-114 (fulvestrant) for HR+/HER- breast cancer; and Vasopressin injection, which is indicated to enhance blood pressure in adults with vasodilatory shock. The company has license and collaboration agreements with Combioxin, SA for the development and commercialization rights to CAL02, an antitoxin agent for the treatment of severe pneumonia in combination with traditional antibacterial drugs; and AOP Orphan Pharmaceuticals GmbH for the commercial rights of Landiolol, a novel therapeutic product candidate for the short-term reduction of ventricular rate in patients with supraventricular tachycardia, including atrial fibrillation and atrial flutter. It has a strategic collaboration with Tyme Technologies, Inc. for the development of SM-88 to treat breast cancer (HR+/HER2-) and high-risk metastatic sarcomas. Eagle Pharmaceuticals, Inc. was incorporated in 2007 and is headquartered in Woodcliff Lake, New Jersey.

Last Close

0.5

Volume

-

Current Price

0.6

Change

19.999999999999996

Last Updated

2025-11-29T12:37:05.430Z

Image

data:image/webp;base64,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

Ipo Date

2014-02-12T00:00:00.000Z

Market Cap

6479114

Next Dividend Date

-

Dividend Frequency

-

Dividend Rate

-

Dividend Yield

0

Sentiment

-

Sentiment Sources

0

Rating

5

Target Price

17

Strong Buy

1

Buy

0

Hold

0

Sell

0

Strong Sell

0

Current Quarter

2023-06-30

Revenue

64646000

Cost Of Revenue

16858000

Gross Profit

47788000

Operating Expenses

37484000

Operating Income

10304000

Interest Expense

1448000

Pretax Income

9298000

Net Income

5164000

Eps

0.39256232744152825

Dividends Per Share

-

Shares Outstanding

12958227

Income Tax Expense

4134000

EBITDA

16326000

Operating Margin

15.939114562385917

Total Other Income Expense Net

-1006000

Cash

15354000

Short Term Investments

-

Receivables

116284000

Inventories

42482000

Total Current Assets

187250000

Property Plant Equipment

1013000

Total Assets

404822000

Payables

15843000

Short Term Debt

9719000

Long Term Debt

61896000

Total Liabilities

152782000

Equity

252040000

Depreciation

5580000

Change In Working Capital

-14232000

Cash From Operations

-126000

Capital Expenditures

6000

Cash From Investing

-6000

Cash From Financing

-6411000

Net Change In Cash

-6543000

PE

3.8462

PB

0.031315503094746865

ROE

2.0488811299793683

ROA

1.2756223723019007

FCF

-132000

Fcf Percent

-0.002041889676082047

Piotroski FScore

2

Health Score

47

Deep Value Investing Score

9

Defensive Investing Score

6.5

Dividend Investing Score

1.5

Economic Moat Investing Score

5.3

Garp Investing Score

2

Growth Investing Score

1.5

Momentum Investing Score

4

Net Net Investing Score

6.5

Quality Investing Score

4.5

Value Investing Score

7.5

Quarters > 0 > quarter

2023-06-30

Quarters > 0 > income Statement > revenue

64646000

Quarters > 0 > income Statement > cost Of Revenue

16858000

Quarters > 0 > income Statement > gross Profit

47788000

Quarters > 0 > income Statement > operating Expenses

37484000

Quarters > 0 > income Statement > operating Income

10304000

Quarters > 0 > income Statement > interest Expense

1448000

Quarters > 0 > income Statement > pretax Income

9298000

Quarters > 0 > income Statement > net Income

5164000

Quarters > 0 > income Statement > eps

0.39256232744152825

Quarters > 0 > income Statement > dividends Per Share

-

Quarters > 0 > income Statement > shares Outstanding

13154599

Quarters > 0 > income Statement > income Tax Expense

4134000

Quarters > 0 > income Statement > EBITDA

16326000

Quarters > 0 > income Statement > operating Margin

15.939114562385917

Quarters > 0 > income Statement > total Other Income Expense Net

-1006000

Quarters > 0 > balance Sheet > cash

15354000

Quarters > 0 > balance Sheet > short Term Investments

-

Quarters > 0 > balance Sheet > receivables

116284000

Quarters > 0 > balance Sheet > inventories

42482000

Quarters > 0 > balance Sheet > total Current Assets

187250000

Quarters > 0 > balance Sheet > property Plant Equipment

1013000

Quarters > 0 > balance Sheet > total Assets

404822000

Quarters > 0 > balance Sheet > payables

15843000

Quarters > 0 > balance Sheet > short Term Debt

9719000

Quarters > 0 > balance Sheet > long Term Debt

61896000

Quarters > 0 > balance Sheet > total Liabilities

152782000

Quarters > 0 > balance Sheet > equity

252040000

Quarters > 0 > cash Flow > net Income

5164000

Quarters > 0 > cash Flow > depreciation

5580000

Quarters > 0 > cash Flow > change In Working Capital

-14232000

Quarters > 0 > cash Flow > cash From Operations

-126000

Quarters > 0 > cash Flow > capital Expenditures

6000

Quarters > 0 > cash Flow > cash From Investing

-6000

Quarters > 0 > cash Flow > cash From Financing

-6411000

Quarters > 0 > cash Flow > net Change In Cash

-6543000

Quarters > 0 > ratios > PE

0.39256232744152825

Quarters > 0 > ratios > PB

0.031315503094746865

Quarters > 0 > ratios > ROE

2.0488811299793683

Quarters > 0 > ratios > ROA

1.2756223723019007

Quarters > 0 > ratios > FCF

-132000

Quarters > 0 > ratios > Piotroski FScore

2

Quarters > 0 > ratios > fcf Percent

-0.002041889676082047

Quarters > 0 > health Score

47

Quarters > 1 > quarter

2023-03-31

Quarters > 1 > income Statement > revenue

66305000

Quarters > 1 > income Statement > cost Of Revenue

17300000

Quarters > 1 > income Statement > gross Profit

49005000

Quarters > 1 > income Statement > operating Expenses

37232000

Quarters > 1 > income Statement > operating Income

6187000

Quarters > 1 > income Statement > interest Expense

1516000

Quarters > 1 > income Statement > pretax Income

10231000

Quarters > 1 > income Statement > net Income

5750000

Quarters > 1 > income Statement > eps

0.43715361752981446

Quarters > 1 > income Statement > dividends Per Share

-

Quarters > 1 > income Statement > shares Outstanding

13153271

Quarters > 1 > income Statement > income Tax Expense

4481000

Quarters > 1 > income Statement > EBITDA

17307000

Quarters > 1 > income Statement > operating Margin

9.331121333232788

Quarters > 1 > income Statement > total Other Income Expense Net

-1542000

Quarters > 1 > balance Sheet > cash

21897000

Quarters > 1 > balance Sheet > short Term Investments

-

Quarters > 1 > balance Sheet > receivables

116022000

Quarters > 1 > balance Sheet > inventories

44140000

Quarters > 1 > balance Sheet > total Current Assets

192491000

Quarters > 1 > balance Sheet > property Plant Equipment

1116000

Quarters > 1 > balance Sheet > total Assets

414175000

Quarters > 1 > balance Sheet > payables

17108000

Quarters > 1 > balance Sheet > short Term Debt

9087000

Quarters > 1 > balance Sheet > long Term Debt

68829000

Quarters > 1 > balance Sheet > total Liabilities

171330000

Quarters > 1 > balance Sheet > equity

242845000

Quarters > 1 > cash Flow > net Income

5750000

Quarters > 1 > cash Flow > depreciation

5560000

Quarters > 1 > cash Flow > change In Working Capital

-48050000

Quarters > 1 > cash Flow > cash From Operations

-33512000

Quarters > 1 > cash Flow > capital Expenditures

58000

Quarters > 1 > cash Flow > cash From Investing

-12558000

Quarters > 1 > cash Flow > cash From Financing

12646000

Quarters > 1 > cash Flow > net Change In Cash

-33424000

Quarters > 1 > ratios > PE

0.43715361752981446

Quarters > 1 > ratios > PB

0.03249794148530956

Quarters > 1 > ratios > ROE

2.367765447095884

Quarters > 1 > ratios > ROA

1.3883020462364943

Quarters > 1 > ratios > FCF

-33570000

Quarters > 1 > ratios > Piotroski FScore

2

Quarters > 1 > ratios > fcf Percent

-0.5062966593771209

Quarters > 1 > health Score

47

Quarters > 2 > quarter

2022-12-31

Quarters > 2 > income Statement > revenue

60699000

Quarters > 2 > income Statement > cost Of Revenue

19866000

Quarters > 2 > income Statement > gross Profit

40833000

Quarters > 2 > income Statement > operating Expenses

31367000

Quarters > 2 > income Statement > operating Income

9466000

Quarters > 2 > income Statement > interest Expense

1980000

Quarters > 2 > income Statement > pretax Income

13304000

Quarters > 2 > income Statement > net Income

8165000

Quarters > 2 > income Statement > eps

0.6221323053304967

Quarters > 2 > income Statement > dividends Per Share

-

Quarters > 2 > income Statement > shares Outstanding

13124218

Quarters > 2 > income Statement > income Tax Expense

5139000

Quarters > 2 > income Statement > EBITDA

21194000

Quarters > 2 > income Statement > operating Margin

15.594985090363927

Quarters > 2 > income Statement > total Other Income Expense Net

3838000

Quarters > 2 > balance Sheet > cash

55321000

Quarters > 2 > balance Sheet > short Term Investments

-

Quarters > 2 > balance Sheet > receivables

73440000

Quarters > 2 > balance Sheet > inventories

47794000

Quarters > 2 > balance Sheet > total Current Assets

188754000

Quarters > 2 > balance Sheet > property Plant Equipment

1168000

Quarters > 2 > balance Sheet > total Assets

406160000

Quarters > 2 > balance Sheet > payables

18993000

Quarters > 2 > balance Sheet > short Term Debt

7784000

Quarters > 2 > balance Sheet > long Term Debt

56216000

Quarters > 2 > balance Sheet > total Liabilities

172600000

Quarters > 2 > balance Sheet > equity

233560000

Quarters > 2 > cash Flow > net Income

8165000

Quarters > 2 > cash Flow > depreciation

5630000

Quarters > 2 > cash Flow > change In Working Capital

29106000

Quarters > 2 > cash Flow > cash From Operations

37557000

Quarters > 2 > cash Flow > capital Expenditures

10000

Quarters > 2 > cash Flow > cash From Investing

-9000

Quarters > 2 > cash Flow > cash From Financing

2389000

Quarters > 2 > cash Flow > net Change In Cash

39937000

Quarters > 2 > ratios > PE

0.6221323053304967

Quarters > 2 > ratios > PB

0.033715237198150366

Quarters > 2 > ratios > ROE

3.495889707141634

Quarters > 2 > ratios > ROA

2.010291510734686

Quarters > 2 > ratios > FCF

37547000

Quarters > 2 > ratios > Piotroski FScore

4

Quarters > 2 > ratios > fcf Percent

0.6185769123049804

Quarters > 2 > health Score

69

Quarters > 3 > quarter

2022-09-30

Quarters > 3 > income Statement > revenue

65901000

Quarters > 3 > income Statement > cost Of Revenue

23651000

Quarters > 3 > income Statement > gross Profit

42250000

Quarters > 3 > income Statement > operating Expenses

32788000

Quarters > 3 > income Statement > operating Income

-2306000

Quarters > 3 > income Statement > interest Expense

1591000

Quarters > 3 > income Statement > pretax Income

-45000

Quarters > 3 > income Statement > net Income

-3513000

Quarters > 3 > income Statement > eps

-0.2668047702232206

Quarters > 3 > income Statement > dividends Per Share

247000

Quarters > 3 > income Statement > shares Outstanding

13166931

Quarters > 3 > income Statement > income Tax Expense

3468000

Quarters > 3 > income Statement > EBITDA

2152000

Quarters > 3 > income Statement > operating Margin

-3.499188176203699

Quarters > 3 > income Statement > total Other Income Expense Net

-1357000

Quarters > 3 > balance Sheet > cash

15384000

Quarters > 3 > balance Sheet > short Term Investments

-

Quarters > 3 > balance Sheet > receivables

97930000

Quarters > 3 > balance Sheet > inventories

63855000

Quarters > 3 > balance Sheet > total Current Assets

185046000

Quarters > 3 > balance Sheet > property Plant Equipment

1297000

Quarters > 3 > balance Sheet > total Assets

390067000

Quarters > 3 > balance Sheet > payables

13215000

Quarters > 3 > balance Sheet > short Term Debt

36469000

Quarters > 3 > balance Sheet > long Term Debt

26431000

Quarters > 3 > balance Sheet > total Liabilities

154669000

Quarters > 3 > balance Sheet > equity

235398000

Quarters > 3 > cash Flow > net Income

-3513000

Quarters > 3 > cash Flow > depreciation

3852000

Quarters > 3 > cash Flow > change In Working Capital

-24460000

Quarters > 3 > cash Flow > cash From Operations

-13237000

Quarters > 3 > cash Flow > capital Expenditures

10000

Quarters > 3 > cash Flow > cash From Investing

-11237000

Quarters > 3 > cash Flow > cash From Financing

3296000

Quarters > 3 > cash Flow > net Change In Cash

-21178000

Quarters > 3 > ratios > PE

-0.2668047702232206

Quarters > 3 > ratios > PB

0.03356085693166467

Quarters > 3 > ratios > ROE

-1.492366120357862

Quarters > 3 > ratios > ROA

-0.9006145098149805

Quarters > 3 > ratios > FCF

-13247000

Quarters > 3 > ratios > Piotroski FScore

0

Quarters > 3 > ratios > fcf Percent

-0.20101364167463318

Quarters > 3 > health Score

29

Valuation > metrics > PE

3.8462

Valuation > metrics > PB

0.031315503094746865

Valuation > final Score

90

Valuation > verdict

79.2% Undervalued

Profitability > metrics > ROE

2.0488811299793683

Profitability > metrics > ROA

2.75781041388518

Profitability > metrics > Net Margin

0.07988119914611887

Profitability > final Score

24

Profitability > verdict

Weak

Risk > metrics > Debt Equity

0.6061815584827805

Risk > metrics > Interest Coverage

7.116022099447513

Risk > final Score

76

Risk > verdict

Low

Liquidity > metrics > Current Ratio

7.325326656756122

Liquidity > metrics > Quick Ratio

5.663406619200376

Liquidity > final Score

100

Liquidity > verdict

Great

Prev Valuations > 0

90

Prev Valuations > 1

90

Prev Valuations > 2

70

Prev Profitabilities > 0

27

Prev Profitabilities > 1

40

Prev Profitabilities > 2

0

Prev Risks > 0

64

Prev Risks > 1

67

Prev Risks > 2

42

Prev Liquidities > 0

100

Prev Liquidities > 1

100

Prev Liquidities > 2

100

Updated At

2025-12-16T22:35:32.126Z